# The Prevalence, Disease Burden and Prognosis of COPD in Patients With Cardiovascular Diseases

> **NCT06909773** · NA · RECRUITING · sponsor: **AstraZeneca** · enrollment: 3000 (estimated)

## Conditions studied

- Cardiovascular Diseases

## Interventions

- **BEHAVIORAL:** Guideline education and implementation intervention

## Key facts

- **NCT ID:** NCT06909773
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-28
- **Primary completion:** 2026-10-28
- **Final completion:** 2026-12-31
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06909773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06909773, "The Prevalence, Disease Burden and Prognosis of COPD in Patients With Cardiovascular Diseases". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06909773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*